SANDRA HUGGINS: Open Payments
NPI 1003072273 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 38 payments from 12 companies in 2025. Trend: 2023 $798 · 2024 $551 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $324 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $101 |
| Lilly USA, LLC | 4 | $69 |
| PFIZER INC. | 3 | $59 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $45 |
| Inspire Medical Systems, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Dexcom, Inc. | 1 | $27 |
Products named: Ozempic, CAPLYTA, MOUNJARO, Rybelsus, GVOKE HYPOPEN, INSPIRE, Wegovy, QULIPTA.
Industry payments across TN — which companies pay providers there.
